Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Bispecific anti-VEGF and anti-TrkB binding molecules for the treatment of eye diseases

Bispecific anti-VEGF and anti-TrkB binding molecules for the treatment of eye diseases

US Patent 12110335 · Granted Oct 8, 2024

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Modulation of transgene expression in plants2025
Glucagon analogues as long-acting GLP-1/glucagon receptor agonists in the treatm2025
Methods and compositions for homology directed repair of double strand breaks in2025
Selective and potent inhibitory antibodies of myostatin activation2025
Anti-PVRIG antibodies and methods of use2025
Anti-PD-1 antibodies2025
Tri-specific binding molecules2025
3'UTR sequence for transgene expression2025
Multi-specific binding proteins for cancer treatment2024
Methods and compositions for modulating a genome2024
Triple combination antibody therapies2024
Bispecific and tetravalent CD137 and FAP molecules for the treatment of cancer2024